Wasabi's kick linked to single pain receptor

A single pain receptor is responsible for the kick delivered by garlic and mustard oil, which is the active ingredient in mustard and in the pungent green sushi condiment known as wasabi, according to a Yale School of Medicine study published this week in Cell.

The sensory receptor also underlies the response to a variety of environmental irritants, such as acrolein, the researchers report. Acrolein accounts for the toxic and inflammatory actions of tear gas, vehicle exhaust, tobacco smoke, and the byproduct of some chemotherapy drugs widely used in the treatment of cancer, severe arthritis, multiple sclerosis, and lupus.

"We identified TRPA1 (the receptor) not only as a promising target for the development of new pain medications, but also for potential new treatments of smoking-related disease and environmental irritation," said Sven-Eric Jordt, co-author and assistant professor in the Department of Pharmacology at Yale.

The researchers examined whether neurons taken from mice lacking the TRPA1 receptor responded normally to the pungent compounds found in mustard oil and garlic. They found neurons from the TRPA1-deficient mice were completely insensitive to either ingredient. In fact, the animals lacking the sensory gene did not flinch or try to lick when mustard oil was applied to their paws. Their paws also swelled less and became less sensitive to pain in response to the mustard oil exposure.

The team also found that TRPA1 is an important target of bradykinin, one of the body's natural inflammatory agents that stimulates pain-sensing neurons and leads to hypersensitivity to heat or touch.

Mice lacking the TRPA1 channel had a normal ability to sense extreme cold and noxious sound, evidence against the suggestions of earlier studies that the channels might also play important roles in cold sensitivity or hearing, they found.

"Pain therapy is one of the major challenges in modern medicine," said Jordt. "Currently, 20 percent of all Americans suffer from chronic or inflammatory pain, associated with arthritis, back injuries, headaches, migraines, and shingles."

"Although we are beginning to understand more about the causes of pain, the pharmacological repertoire of pain medications is still very limited. Most of the chemical substances from which current pain therapeutics are derived were discovered more than 100 years ago," he said. "Thus, the development of new pain medications is urgently needed to fill the therapeutic gaps and to treat additional forms of pain."

Source: Yale University

Related stories:

Researchers discover paradox about general anesthesia: It can increase post-surgical pain
The general anesthesia that puts patients into unconscious sleep so they do not feel surgical pain can increase the discomfort they feel once they wake up, say researchers from Georgetown University Medical Center. They say their findings, the first to scientifically explain what has been anecdotally observed in the clinic, may lead to wider use of the few anesthetics that don't have this side effect, or to the development of new ones.

Too hot to handle! Scientists identify heat sensing regulator
Neuroscientists at Johns Hopkins are a step closer to understanding pain sensitivity - specifically why it’s variable instead of constant - having identified a gene that regulates a heat-activated molecular sensor. Their description of the function of a membrane protein called Pirt appears in the May 2 issue of Cell.
Tarantula venom and chili peppers target same pain sensor
Venom from a West Indian tarantula has been shown to cause pain by exciting the same nerve cells in mice that sense high temperatures and the hot, spicy ingredient in chili peppers, UCSF scientists have discovered.
No longer depressed, or on meds
Henry Quant was just 5 years old and bedridden with chronic fevers when he began taking pills for anxiety and depression. His mother knew that the drugs helped, but they made her nervous.
Understanding Algae As An Alternative Fuel Source: Will The Real Algae X Please Stand Up
The recent creation of AXI, LLC is an alliance between Allied Minds, Inc. a seed investment company and the University of Washington. The alliance came about because of Professor Rose Ann Cattolico PhD, an algae-to-fuel expert. Professor Cattolico has been on the faculty and conducting algae research since 1975. Her research includes, chloroplast genome architecture and gene function in non-chlorophy b containing algae and functional genetic diversity within stramenopile population. Professor Cattolico has discovered a unique patented technology, she calls Algae X.
Pill that boosts productivity gaining favor, raising concerns among medical ethicists
In a place like Silicon Valley, where career prospects often hinge on a person's intelligence and ability to work hellishly long hours, "brain doping" probably was inevitable.
Nano vaccine for hepatitis B shows promise for third world
Chronic hepatitis B infects 400 million people worldwide, many of them children. Even with three effective vaccines available, hepatitis B remains a stubborn, unrelenting health problem, especially in Africa and other developing areas. The disease and its complications cause an estimated 1 million deaths globally each year.
Low vitamin D levels pose large threat to health
Researchers at Johns Hopkins are reporting what is believed to be the most conclusive evidence to date that inadequate levels of vitamin D, obtained from milk, fortified cereals and exposure to sunlight, lead to substantially increased risk of death.

News discussion:

General Science news